EUVIMEDEUVIMED entdecken
Kohortenstudie

Circulating microRNAs as biomarkers in pediatric epilepsy: A longitudinal cohort study

Licia Salimbene iD, Mattia Mercier iD, Valentina Spedaletti iD, Angela De Dominicis iD, Costanza Calabrese iD, Cristina Filosomi iD, Emanuela Angelucci iD, Vittorio Rosato iD, Marco Cappa iD, Federico Vigevano iD, Luca de Palma iD, Marina Trivisano iD und 1 weitere

Epilepsia · 2026-06 · 67 (6) · 3058-3069

DOI: 10.1002/epi.70166 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Epilepsia, online erschienen am 27.02.2026. Verfasst von Licia Salimbene und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neurology, Epilepsy, and Movement Disorders, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, full member of Euro…. Hauptthemen laut MEDLINE: Epilepsy, MicroRNAs, Circulating MicroRNA. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Ministry of University and Research, National Recovery and Resilience Plan, Italian Ministry of Health with Current Research Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Epilepsy is the most common chronic neurological disorder in children, and approximately one third of patients develop drug‐resistant seizures. Reliable biomarkers are needed to improve diagnosis, prognostic assessment, and treatment monitoring. This study evaluated four circulating microRNAs—miR‐15a‐5p, miR‐106b‐5p, miR‐146a‐5p, and miR‐152‐3p—as potential diagnostic and prognostic biomarkers in pediatric epilepsy.

Methods

A total of 122 pediatric patients with epilepsy and 29 age‐ and sex‐matched healthy controls were prospectively enrolled at Bambino Gesù Children's Hospital (Rome) between 2022 and 2025. Clinical variables included epilepsy type, etiology, seizure frequency, electroencephalography, magnetic resonance imaging, and comorbidities. Serum miRNAs were measured by reverse transcription quantitative polymerase chain reaction and normalized using the 2 −ΔΔCt method, accounting for hemolysis. Nonparametric tests (Mann–Whitney, Kruskal–Wallis, Wilcoxon) were used for comparisons. Forty‐three patients were reevaluated after ≥12 months to assess longitudinal expression.

Results

All four miRNAs were significantly upregulated in children with epilepsy compared to controls ( p < .05). miR‐146a‐5p expression differed among etiological groups, being higher in structural compared with genetic or unknown etiologies ( p = .014). Both miR‐15a‐5p and miR‐106b‐5p correlated with seizure frequency, showing greater expression in patients with monthly‐to‐daily seizures than in those with sporadic seizures or seizure‐free patterns ( p = .004 and p = .017). No association was found with antiseizure medications, intellectual disability, or psychiatric comorbidities. Longitudinal analysis showed a significant increase in miR‐15a‐5p and miR‐106b‐5p at follow‐up ( p < .01), independent of clinical outcome, whereas miR‐146a‐5p remained stable over time. These findings suggest that miR‐15a‐5p and miR‐106b‐5p reflect ongoing epileptic activity, whereas miR‐146a‐5p may relate to underlying pathophysiology rather than seizure dynamics. Significance Circulating miRNAs represent promising, minimally invasive biomarkers in pediatric epilepsy. miR‐146a‐5p may aid etiologic classification, whereas miR‐15a‐5p and miR‐106b‐5p could serve as dynamic indicators of disease burden and treatment response, supporting biomarker‐driven precision approaches in epilepsy care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyMicroRNAsCirculating MicroRNAHumansFemaleChildBiomarkersMaleLongitudinal StudiesChild, PreschoolAdolescentProspective StudiesElectroencephalography

Stichwörter der Autor:innen

biomarkerlongitudinal analysismicroRNApediatric epilepsyseizure frequency

Substanzen

BiomarkersMicroRNAsCirculating MicroRNAMIRN146 microRNA, humanMIRN106 microRNA, human

Autor:innen und Institutionen

  • Neurology, Epilepsy, and Movement Disorders, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, full member of European Reference Network EpiCARE, Rome, Italy.
  • Department of Physiology, Behavioral Neuroscience PhD Program, Sapienza University, Rome, Italy.
  • Genechron, Rome, Italy.
  • Research Unit Innovative Therapies for Endocrinopathies, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, Italy.
  • Pediatric Neurorehabilitation, San Raffaele Hospital, Scientific Institute for Research and Health Care, Rome, Italy.
  • University Hospitals KU Leuven, Leuven, Belgium.

ORCID-Profile: Licia Salimbene, Mattia Mercier, Valentina Spedaletti, Angela De Dominicis, Costanza Calabrese, Cristina Filosomi, Emanuela Angelucci, Vittorio Rosato, Marco Cappa, Federico Vigevano, Luca de Palma, Marina Trivisano, Nicola Specchio

Förderung

  • Ministry of University and Research
  • National Recovery and Resilience Plan
  • Italian Ministry of Health with Current Research Funds
  • UniCredit Foundation
  • AISIWH ETS OdV (Italian Association of Wolf-Hirschhorn Syndrome)

Zitieren

APA

Salimbene, L., Mercier, M., Spedaletti, V., De Dominicis, A., Calabrese, C., Filosomi, C., Angelucci, E., Rosato, V., Cappa, M., Vigevano, F., de Palma, L., Trivisano, M., & Specchio, N. (2026). Circulating microRNAs as biomarkers in pediatric epilepsy: A longitudinal cohort study. Epilepsia, 67(6), 3058-3069. https://doi.org/10.1002/epi.70166

Vancouver

Salimbene L, Mercier M, Spedaletti V, De Dominicis A, Calabrese C, Filosomi C, et al. Circulating microRNAs as biomarkers in pediatric epilepsy: A longitudinal cohort study. Epilepsia. 2026;67(6):3058-3069. doi:10.1002/epi.70166

BibTeX
@article{Salimbene2026,
  author = {Salimbene, Licia and Mercier, Mattia and Spedaletti, Valentina and De Dominicis, Angela and Calabrese, Costanza and Filosomi, Cristina and Angelucci, Emanuela and Rosato, Vittorio and Cappa, Marco and Vigevano, Federico and de Palma, Luca and Trivisano, Marina and Specchio, Nicola},
  title = {Circulating microRNAs as biomarkers in pediatric epilepsy: A longitudinal cohort study},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {6},
  pages = {3058--3069},
  doi = {10.1002/epi.70166}
}
Kostenlos starten →